Health economics of disease-modifying therapy for multiple sclerosis in the United States by Daniel M. Hartung

Get full text

Association of economic and racial segregation with restricted buprenorphine dispensing in U.S. community pharmacies by Kyle J. Moon, Sabriya L. Linton, Neda J. Kazerouni, Ximena A. Levander, Adriane N. Irwin, Daniel M. Hartung

Get full text

Evaluation of a Medicaid performance improvement project to reduce high-dose opioid prescriptions by Daniel M. Hartung, Jonah Geddes, Sara E. Hallvik, P. Todd Korthuis, Luke Middleton, Gillian Leichtling, Christi Hildebran, Hyunjee Kim

Get full text

Sedative-hypnotic Co-prescribing with Opioids in a Large Network of Community Health Centers by Daniel M. Hartung, Jennifer A. Lucas, Nathalie Huguet, Steffani R. Bailey, Jean O’Malley, Robert W. Voss, Irina Chamine, John Muench

Get full text

Reducing overdose after release from incarceration (ROAR): study protocol for an intervention to reduce risk of fatal and non-fatal opioid overdose among women after release from p... by Elizabeth Needham Waddell, Robin Baker, Daniel M. Hartung, Christi J. Hildebran, Thuan Nguyen, Deza’Rae M. Collins, Jessica E. Larsen, Erin Stack, the ROAR Protocol Development Team

Get full text

Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study by Daniel M. Hartung, Sheila Markwardt, Kirbee Johnston, Jonah Geddes, Robin Baker, Gillian Leichtling, Christi Hildebran, Brian Chan, Ryan R. Cook, Dennis McCarty, Udi Ghitza, P. Todd Korthuis

Get full text

Policies, adaptations, and ongoing challenges to naloxone, buprenorphine and nonprescription syringe access across four-states: Findings from an environmental scan and key informan... by Anthony S. Floyd, Joseph Silcox, Gail Strickler, Thuong Nong, Malcolm Blough, Derek Bolivar, Megan Rabin, Jeffrey Bratberg, Adriane N. Irwin, Daniel M. Hartung, Ryan N. Hansen, Robert Bohler, Traci C. Green

Get full text